prophylaxis是什么意思，预防翻译-生物医药大词典
您现在的位置： >>
>> 词汇解释: prophylaxis
prophylaxis
分类：&&&&&&&相关的句子：&&&|&&&&&&&|&&&&
以下为句子列表：
英文: Abstract: Objective：To evaluate the value of antibiotic prophylaxis in cholecys tectomy. 中文:
文摘:目的：探讨胆囊切除术预防性应用抗生素的价值。&&&&&&&
英文: BACKGROUND: The aim of this study is to evaluate the rate of infectious complications post endoscopic transspheinodal neurosurgery in patients receiving a new antibiotic chemoprophylaxis regimen. 中文:
背景∶评估患者接受经内窥镜显微神经外科手术加用新的抗菌素后的感染性并发症。&&&&&&&
英文: CONCLUSION: This study indicates the need for interventions to improve the rational use of antibiotic prophylaxis in Iran to prevent the complications of inappropriate administration of antimicrobials and decrease unnecessary costs. 中文:
结论：本研究提示需要对伊朗的预防性应用抗生素进行干预，阻止滥用抗生素带来的并发症，降低不必要的医疗费用。&&&&&&&
英文: However, since the introduction of highly active antiretroviral therapy (HAART) and prophylaxis against opportunistic pathogens, death rates from AIDS have begun to decline significantly. 中文:
自从最近应用了强作用抗病毒治疗HAART和对各种机会性感染的预防治疗后，艾滋病人的死亡率明显下降。&&&&&&&
英文: Objective：To evaluate the value of antibiotic prophylaxis in cholecys tectomy. 中文:
目的：探讨胆囊切除术预防性应用抗生素的价值。&&&&&&&
赞助商链接
你知道它的英文吗？
你知道中文意思吗？
& 生物医药大词典- 自日开始服务
由团队研发Anturan for secondary prophylaxis of myocardial infarction.
- PubMed - NCBI
The NCBI web site requires JavaScript to function.
FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListChoose DestinationFileClipboardCollectionsE-mailOrderMy BibliographyCitation managerFormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSVCreate File1 selected item: 2465979FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other DataE-mailSubjectAdditional textE-mailAdd to ClipboardAdd to CollectionsOrder articlesAdd to My BibliographyGenerate a file for use with external citation management software.Create File
):595-8.Anturan for secondary prophylaxis of myocardial infarction.1, , , , , , .1Department of Internal Medicine, Lumumba University, USSR.Abstract273 patients suffering from ischemic heart disease were treated with Anturan for one year at a daily dosage of 800 mg. The number of cardiovascular complications was significantly reduced, compared to the control group.PMID: 2465979
[PubMed - indexed for MEDLINE]
MeSH TermsSubstancesMedicalMolecular Biology Databases
Supplemental Content
External link. Please review our .secondary-prophylaxis是什么意思_百度作业帮
拍照搜题，秒出答案
secondary-prophylaxis是什么意思
secondary-prophylaxis是什么意思
secondary prophylaxis二级预防Comparison of in-hospital secondary prevention for different vascular diseases.
- PubMed - NCBI
The NCBI web site requires JavaScript to function.
FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListChoose DestinationFileClipboardCollectionsE-mailOrderMy BibliographyCitation managerFormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSVCreate File1 selected item: FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other DataE-mailSubjectAdditional textE-mailAdd to ClipboardAdd to CollectionsOrder articlesAdd to My BibliographyGenerate a file for use with external citation management software.Create File
):631-5. doi: 10.1016/j.ejim.. Epub
2009 Aug 6.Comparison of in-hospital secondary prevention for different vascular diseases.1, , , , , .1Intensive Care Unit, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. andreas.perren@eoc.chAbstractBACKGROUND: Secondary prevention of coronary artery disease is highly effective and implemented on a large scale. However, studies testing adherence to recommended secondary prevention of other vascular diseases are rare. Our goal was to evaluate whether the kind of vascular disease influences prescription practice of secondary drug prophylaxis at hospital discharge and to which extent secondary prevention is actually complete.METHODS: A 3-month prospective observational review of the hospital discharge information of all patients hospitalized because of a vascular disease diagnosis: coronary artery disease (i.e. acute myocardial infarction [AMI] and chronic stable angina [CSA]); peripheral artery disease [PAD] and cerebrovascular disease [CVD]. The analysis was done by board registered internists with a structured form that founded on internationally accepted recommendations.RESULTS: From 271 patients 191 had coronary artery disease (105 AMI and 86 CSA), 88 PAD and 72 CVD. Global prescription rate ( 95% CI) of indicated secondary prophylaxis drugs was 74.1% (69.9-78.2) for AMI, 72.4% (67.2-77.5) for CSA, 74.7% (68.8-80.7) for PAD and 72.1% (66.9-77.3) for CVD. The proportion of patients who were prescribed a complete bundle of recommended medications was globally 29.5% (24.1-35.0).CONCLUSIONS: We found similar global prescription rates of secondary prevention for the different vascular diseases. However, only one third of the studied collective gets a complete set of required prophylactic drugs.PMID:
[PubMed - indexed for MEDLINE]
MeSH TermsFull Text SourcesOther Literature SourcesMedical
Supplemental Content
External link. Please review our .The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.
- PubMed - NCBI
The NCBI web site requires JavaScript to function.
FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListChoose DestinationFileClipboardCollectionsE-mailOrderMy BibliographyCitation managerFormatSummary (text)Abstract (text)MEDLINEXMLPMID ListCSVCreate File1 selected item: FormatSummarySummary (text)AbstractAbstract (text)MEDLINEXMLPMID ListMeSH and Other DataE-mailSubjectAdditional textE-mailAdd to ClipboardAdd to CollectionsOrder articlesAdd to My BibliographyGenerate a file for use with external citation management software.Create File
):424-33. doi: 10.1111/bjh.12267. Epub
2013 Feb 22.The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.1, , , , , , , ; .1Indiana Hemophilia and Thrombosis Center, Indianapolis, IN 46260, USA. sgupta@ihtc.orgAbstractThis study prospectively compared the effect of secondary prophylaxis to episodic treatment on target joint (TJ) range of motion (ROM), number of joint haemorrhages and new TJ development in patients with moderate or severe haemophilia. Two-hundred and eighty-six males, 17% in prophylaxis, 83% in episodic treatment group, participating in the Centers for Disease Control and Prevention's Universal Data Collection project, fulfilled inclusion criteria: age &2 years at enrollment, free of TJs at enrollment, developed at least one TJ after enrollment, and received either prophylaxis or episodic treatment continuously for two follow-up visits after TJ development. The outcomes of interest - percentage change in TJ ROM, number of joint haemorrhages and new TJ development, were modelled using multivariate linear, Poisson and logistic regression techniques respectively. Individuals who received secondary prophylaxis in comparison to episodic treatment were younger at TJ development (P & 0.01); there was no difference in the decrease in TJ ROM between the two groups (P = 0.9). Factors significantly associated with a higher rate of haemarthroses included episodic treatment, severe haemophilia, age &5 years at TJ development, obesity and inhibitor negative status. Secondary prophylaxis significantly decreased haemarthroses but was not associated with a significant improvement in TJ ROM or with new TJ development.(C) 2013 Blackwell Publishing Ltd.PMID:
[PubMed - indexed for MEDLINE]
Publication TypesMeSH TermsSubstancesGrant SupportFull Text SourcesOther Literature SourcesMedical
Supplemental Content
External link. Please review our .